Physician profile
Jessie M Dotson
NPI 1740471168
$2,813.23
in general payments reported to CMS, 2019-2025
15 companies · $775 in 2025
The $775 reported for 2025 was more than what 91% of Community Health/Public Health providers received nationally (typical 2025 total: $78.84).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $496 · 2022: $474 · 2023: $739 · 2024: $329 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,842.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $666.68 | 2021-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $489.04 | 2021-2023 | |
| Medtronic, INC. | $418.11 | 2021-2024 | Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $170.41 | 2025 | Evoke |
| Biotronik Nro, INC. | $143.48 | 2025 | Prospera |
| Globus Medical, INC. | $141.84 | 2025 | Senza |
| Averitas Pharma INC. | $139.93 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $124.99 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $124.98 | 2023 | Iovera |
| Stryker Corporation | $121.91 | 2025 | Mild Device Kit |
| Si-Bone, INC. | $109.09 | 2021 | |
| Collegium Pharmaceutical, INC. | $97.70 | 2021-2023 | Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.54 | 2023 | Relistor |
| Abbvie INC. | $15.77 | 2023 | |
| Grt US Holding, INC. | $14.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessie Dotson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.